ImmunGene (Focused Interferon Therapeutics) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

ImmunGene (Focused Interferon Therapeutics) General Information

Description

A proprietary targeted antibody-interferon fusion technology with potential broad application in oncology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 558 Street Charles Drive
  • Suite 200
  • Thousand Oaks, CA 91360
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 558 Street Charles Drive
  • Suite 200
  • Thousand Oaks, CA 91360
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunGene (Focused Interferon Therapeutics) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ImmunGene (Focused Interferon Therapeutics)‘s full profile, request access.

Request a free trial

ImmunGene (Focused Interferon Therapeutics) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ImmunGene (Focused Interferon Therapeutics)‘s full profile, request access.

Request a free trial

ImmunGene (Focused Interferon Therapeutics) FAQs

  • Where is ImmunGene (Focused Interferon Therapeutics) headquartered?

    ImmunGene (Focused Interferon Therapeutics) is headquartered in Thousand Oaks, CA.

  • What industry is ImmunGene (Focused Interferon Therapeutics) in?

    ImmunGene (Focused Interferon Therapeutics)’s primary industry is Buildings and Property.

  • Is ImmunGene (Focused Interferon Therapeutics) a private or public company?

    ImmunGene (Focused Interferon Therapeutics) is a Private company.

  • What is the current valuation of ImmunGene (Focused Interferon Therapeutics)?

    The current valuation of ImmunGene (Focused Interferon Therapeutics) is .

  • What is ImmunGene (Focused Interferon Therapeutics)’s current revenue?

    The current revenue for ImmunGene (Focused Interferon Therapeutics) is .

  • Who are ImmunGene (Focused Interferon Therapeutics)’s investors?

    ImmunGene has invested in ImmunGene (Focused Interferon Therapeutics).

  • When was ImmunGene (Focused Interferon Therapeutics) acquired?

    ImmunGene (Focused Interferon Therapeutics) was acquired on 09-May-2019.

  • Who acquired ImmunGene (Focused Interferon Therapeutics)?

    ImmunGene (Focused Interferon Therapeutics) was acquired by Spectrum Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process